Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pirfenidone exerts beneficial effects in patients with
IPF
undergoing single lung transplantation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-03
DOI
10.1111/ajt.15378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome
- (2018) Y. Dotan et al. CHEST
- Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis
- (2018) Christopher Lambers et al. EUROPEAN RESPIRATORY JOURNAL
- Transcriptome profiling reveals the complexity of pirfenidone effects in IPF
- (2018) Grazyna Kwapiszewska et al. EUROPEAN RESPIRATORY JOURNAL
- Lung volumes predict survival in patients with chronic lung allograft dysfunction
- (2017) Nikolaus Kneidinger et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study
- (2017) Argyrios Tzouvelekis et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
- (2016) Takekazu Iwata et al. ANNALS OF THORACIC SURGERY
- Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates
- (2016) Thomas Weig et al. ANNALS OF THORACIC SURGERY
- Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
- (2016) Isabelle Delanote et al. BMC Pulmonary Medicine
- Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies
- (2015) T. Kauke et al. TISSUE ANTIGENS
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Munich Lung Transplant Group: Waiting List during the First 9 Months of the Lung Allocation Score Era
- (2013) Nikolaus Kneidinger et al. THORACIC AND CARDIOVASCULAR SURGEON
- Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft Rejection
- (2012) Peyman Bizargity et al. TRANSPLANTATION
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Pirfenidone Inhibits T-Cell Activation, Proliferation, Cytokine and Chemokine Production, and Host Alloresponses
- (2009) Gary A. Visner et al. TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started